Etanercept (Enbrel) is a tumor necrosis factor (TNF) inhibitor used for treating rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
A federal judge blocked Colorado's price cap on Amgen's arthritis drug Enbrel, ruling it violated federal patent law and threatened irreparable harm. The injunction preserves Amgen's pricing strategy
ChemBrief